Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
2024-11-13 7:14 pm Purchase | 13G | MAXCYTE INC. MXCT | CADIAN CAPITAL MANAGEMENT LP | 8,188,948 7.800% | 2,544,050 (+45.07%) | View |
2024-11-08 5:31 pm Unchanged | 13G | MAXCYTE INC. MXCT | 10,425,244 9.900% | 0 (Unchanged) | View | |
2024-10-31 4:23 pm Sale | 13G | MAXCYTE INC. MXCT | INTEGRATED CORE STRATEGIES (US) LLC | 4,192,865 4.000% | -1,556,150 (-27.07%) | View |
2024-10-21 4:11 pm Purchase | 13G | MAXCYTE INC. MXCT | 10,425,244 9.900% | 10,425,244 (New Position) | View | |
2024-03-25 4:36 pm Purchase | 13G | MAXCYTE INC. MXCT | INTEGRATED CORE STRATEGIES (US) LLC | 5,749,015 5.500% | 736,732 (+14.70%) | View |
2024-02-14 4:26 pm Sale | 13G | MAXCYTE INC. MXCT | Casdin Capital LLC | 0 0.000% | -9,220,000 (Position Closed) | View |
2024-02-14 12:25 pm Purchase | 13G | MAXCYTE INC. MXCT | CADIAN CAPITAL MANAGEMENT LP | 5,644,898 5.500% | 5,644,898 (New Position) | View |
2024-02-13 5:09 pm Purchase | 13G | MAXCYTE INC. MXCT | VANGUARD GROUP INC | 5,282,108 5.090% | 5,282,108 (New Position) | View |
2024-02-01 4:25 pm Sale | 13G | MAXCYTE INC. MXCT | INTEGRATED CORE STRATEGIES (US) LLC | 5,012,283 4.800% | -758,611 (-13.15%) | View |
2024-01-26 11:49 am Purchase | 13G | MAXCYTE INC. MXCT | BlackRock Inc. BLK | 8,264,933 8.000% | 531,720 (+6.88%) | View |
2023-11-17 4:05 pm Purchase | 13G | MAXCYTE INC. MXCT | INTEGRATED CORE STRATEGIES (US) LLC | 5,770,894 5.600% | 5,770,894 (New Position) | View |
2023-02-14 10:15 am Sale | 13G | MAXCYTE INC. MXCT | BAMCO INC | 2,182,982 2.140% | -2,948,852 (-57.46%) | View |
2023-02-13 2:08 pm Sale | 13G | MAXCYTE INC. MXCT | Sofinnova Crossover I | 4,610,693 4.500% | -500,000 (-9.78%) | View |
2023-01-31 1:58 pm Purchase | 13G | MAXCYTE INC. MXCT | BlackRock Inc. BLK | 7,733,213 7.600% | 890,253 (+13.01%) | View |
2023-01-10 4:48 pm Sale | 13G | MAXCYTE INC. MXCT | Casdin Capital LLC | 9,220,000 9.020% | -4,751,334 (-34.01%) | View |
2022-02-15 2:06 pm Purchase | 13G | MAXCYTE INC. MXCT | BAMCO INC | 5,131,834 5.070% | 5,131,834 (New Position) | View |
2022-02-11 10:59 am Purchase | 13G | MAXCYTE INC. MXCT | Sofinnova Crossover I | 5,110,693 5.100% | 5,110,693 (New Position) | View |
2022-02-04 4:12 pm Purchase | 13G | MAXCYTE INC. MXCT | BlackRock Inc. BLK | 6,842,960 6.800% | 6,842,960 (New Position) | View |
2021-08-03 5:16 pm Purchase | 13G | MAXCYTE INC. MXCT | Casdin Capital LLC | 13,971,334 14.200% | 13,971,334 (New Position) | View |